Student Spotlight


Gwen Gunn

Project Title: Assessing novel suppression and combination therapies for the treatment of MPS I-H
David Bedwell, PhD
Department: Microbiology
Undergrad: BS, University of Maryland, College Park

Welcome to the Cell, Molecular, and Developmental Biology (CMDB) PhD Theme, a part of the Graduate Biomedical Sciences program at the University of Alabama at Birmingham School of Medicine. The CMDB theme is designed to provide maximum flexibility that results in students who are prepared to launch into a career in the emerging biomedical science field. Our graduates have exciting careers in scientific research in both academic and industrial settings; scientific-related writing, business, law, bioterrorism, forensics, administration, and education. 

About Us: CMDB is a cross-disciplinary theme at a leading research University in the sunny south, consisting of a diverse group of scientists and physicians who have a collective interest in fundamental processes in cell, molecular, and developmental biology and how alterations in these processes result inhuman diseases and birth defects.

About UAB: We are consistently one of the top 25 NIH funded research institutions in the U.S. and with faculty from over 30 departments across campus there are many opportunities for you in new and exciting areas of biomedical research. And, UAB is a leader in innovative technology such as whole genome sequencing, electron microscopy, mass spectrometry, crystallography, flow cytometry, drug discovery and others.

Contact Us: We are always searching for the brightest and most dedicated students to join our highly competitive CMDB theme and experience firsthand our cutting edge science. This is your personal invitation to explore the many possible opportunities offered by CMDB at UAB. Please explore this web site and apply today!
  • UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.Andres ForeroA new University of Alabama at Birmingham research study reports that brentuximab vedotin is an effective and safe first course of treatment for older patients with Hodgkin lymphoma that cannot be treated with conventional combination chemotherapy. Results of the study, led by Andres Forero, M.D., professor in the UAB Division of Hematology and Oncology, were published online last month in Blood, the journal of the American Society of Hematology. In 2014, about 9,190 patients were diagnosed with Hodgkin lymphoma in the United States, and up to 20 percent of newly diagnosed Hodgkin Lymphoma patients are 60 years of age or older. While standard chemotherapy can achieve complete remissions and cures in younger patients with Hodgkin lymphoma, the majority of those 60 and older either are ineligible because of other serious medical conditions...

  • Discover artists in their studios, participate in workshops and demonstrations, and purchase artwork to support UAB Department of Art and Art History student scholarships.Visit artists in their studios and buy original artwork at Platform1, a visual arts event benefiting student scholarships, Saturday, Oct. 17, at the University of Alabama at Birmingham’s 2300 Studios. Art Studio faculty from the College of Arts and Sciences’ Department of Art and Art History will open their studios for exhibitions featuring student and alumni artists, hands-on demonstrations, and a silent auction. The event will take place from 5-8 p.m. at 2300 Seventh Ave. South. The event is free and open to the public. Artwork sales are cash or check and carry; 100 percent of sales will fund student scholarships. For more information, contact Outreach Coordinator Jared Ragland at Featured at Platform1: Book and paper arts exhibition with works by alumni and current students Bookbinding demonstrations by members of Medium:...

  • E. coli ClpB is a bacterial enzyme that untangles proteins. Such tangles are hallmarks of neurodegenerative diseases like Parkinson’s and Alzheimer’s. A study led by UAB's Aaron Lucius, Ph.D., offers new insight on this amazing molecular machine, and could eventually point toward new treatment approaches.A marvelous molecular motor that untangles protein in bacteria may sound interesting, yet perhaps not so important. Until you consider the hallmarks of several neurodegenerative diseases — Huntington’s disease has tangled huntingtin protein, Parkinson’s disease has tangled α-synuclein, and Alzheimer’s disease has tangles of tau and β-amyloid. In fact, a similar untangling motor from yeast has already shown effectiveness in mouse and nematode models of Huntington’s disease. Aaron LuciusSo Aaron Lucius, Ph.D., professor in the University of Alabama at Birmingham Department of Chemistry, is studying the bacterial protein ClpB of E. coli, as a steppingstone to expanded research on medically significant models in coming years. The question is...

Epi Menu